References

nogr

Экспериментальная и клиническая гастроэнтерология

Experimental and Clinical Gastroenterology

1682-8658

«Global Media Technologies»

nogr-350

Research Article

ЛЕКЦИЯ

LECTION

ПРОБИОТИКИ В ТЕРАПИИ ЗАБОЛЕВАНИЙ КИШЕЧНИКА У ДЕТЕЙ

PROBIOTICS IN CHILDREN INTESTINAL DISEASES THERAPY

Новикова

В. П.

Novikova

V. P.

novikova-vp@mail.ru

Богданова

Н. М.

Bogdanova

N. M.

noemail@neicon.ru

ФГБУ «СЗ ФМИЦ им. В. А. Алмазова» Минздрава РоссииРоссияFederal North-West Medical research Centre n. a. V. A. AlmazovRussian Federation

2016

20122016

0127883

2016

Новикова В.П., Богданова Н.М.

Novikova V.P., Bogdanova N.M.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.nogr.org/jour/article/view/350

В статье приведены современные представления о пробиотиках, критериях их использования, механизмам защитного действия. Приведены показания к использованию пробиотиков при гастоэнтерологичпских заболеваниях у детей согласно критериям доказательной медицины. Значительная часть материала посвящена позитивной роли штамма Bifidobacterium animalis subsp. lactis пробиотиков при лечении и профилактике гастроэнтерологической патологии у детей.

The article presents a review of the literature on modern concepts about probiotics, criteria for their use, mechanisms of protective action. Given the indications for the use of probiotics for gastroenterologicheskih diseases in children according to the criteria of evidence-based medicine. Much of the material on the positive role of the strain Bifidobacterium animalis subsp. lactis probiotics in the treatment and prevention of gastroenterological patologii in children.

кишечная микрофлорапробиотикииммунитет

toll-like рецепторы (TLRs)intestinal microfloraprobioticsimmunitytoll-like receptors (TLRs)

References1

FAO/WHO. Working group on drafting guidelines for the evaluation of probiotics in food. Guidelines for the evaluation of probiotics in food. 2002. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.

Huff BA. Caveat emptor. “Probiotics” might not be what they seem. Can Fam Physician. 2004;50:583-7.

Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science. 1965;147:747-8.

Parker RB. Probiotics, the other half of the antibiotic story. Animal Nutr Health. 1974;29:4-8.

Tissier H. Tritement des infections intestinales par la methode de translormation de la flore bacterienne de l’intestin. C R Soc Biol. 1906;60:359-61.

FAO/WHO. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food. 2001. ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf.

ANMAT. Alimentos Funcionales Probióticos. 2010. http://www.anmat.gov.ar/consumidores/alimentos/Alimentos_Funcionales Probioticos.pdf.

Elmer GW, et al. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. 1996;275:870-6.

Gorbach SL. Prebióticos y lácteos fermentados: sus beneficios para la salud. Infect Dis Clin Pract Esp. 1995;3:2-7.

Henriquez Moya M, Moreno C. Probióticos: Legislación en Marcha. Dirección Nacional de Alimentos. Secretaria de Agricultura, Ganadería, Pesca y Alimentos. 2009. http://www.alimentosargentinos.gov.ar/03/revistas/r_39/articulos/Probioticos.htm.

WGO. Probióticos y Prebióticos. World Gastroenterology Organisation. 2008. http://www.worldgastroenterology.org/assets/downloads/es/pdf/guidelines/19_probioticos_prebioticos_es.pdf. Accessed 2 Sept 2010.

Borchers AT, et al. Probiotics and immunity. J Gastroenterol. 2009;44:26-46.

Indriyani S. Effects of live versus heat-killed probiotics on acute diarrhea in young children. Indriyani Paediatr Indones. 2012;52:249-54.

Chen X, et al. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J Biol Chem. 2006;281:24449-54.

Lutgendorff F, et al. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med. 2008;8:282-98.

Donkor ON, et al. Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure. Clin Exp Immunol. 2012;167:282-95.

Guarino A, et al. Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol. 2009;25:18-23.

Cruchet S., Furnes R., Maruy A., Hebel E., Palacios J., F. Medina, N. Ramirez, M. Orsi, L. Rondon, V. Sdepanian, L. Xóchihua, M. Ybarra, R. A. Zablah. The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American Experts.Pediatric Drugs June 2015, Volume 17, Issue 3, pp 199-216

Vandenplas Y., Greef E. De, Devreker T., Veereman-WautersAffiliated withPediatric Gastroenterology, UZ Brussel, Vrije Universiteit Brussel G., Hauser B. Probiotics and Prebiotics in Infants and Children. Current Infectious Disease Reports. June 2013, Volume 15, Issue 3, pp 251-262

Vandenplas Y. Probiotics and Prebiotics in infectious gastroenteritis. Best practice & Research clinical gastroenterology 30 (2016)49-53

Хавкин А. И. (под редакцией). Микрофлора пищеварительного тракта - М.: Фонд социальной педиатрии, 2006., 416с.

Урсова Н. И. Дисбактериозы кишечника в детском возрасте: инновации в диагностике, коррекции и профилактике. Руководстводля врачей. М., 2013.328с.

Микробиота желудочно-кишечного тракта при хроническом гастрите/ под ред.А.Н.Суворова, В. П. Новиковой, И. Ю. Мельниковой ИнформМед, 2014. -210с.

Guyatt GH, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.

CEBM. Oxford Centre for Evidence-Based Medicine - levels of evidence. Centre for Evidence-Based Medicine. 2009. http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009

Szajewska H, et al. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr. 2006;42:454-75.

Saavedra JM, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344:1046-9.

Chouraqui JP, et al. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr. 2004;38:288-92.

Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents // Pediatrics. 2005. Vol. 115. № 1. P. 5-9.

Corrêa N. B., Péret Filho L. A., Penna F. J. et al. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibioticassociated diarrhea in infants // J. Clin. Gastroenterol. 2005. Vol. 39. № 5. P. 385-389.

Chatterjee, S.; Kar, P.; Das, T.; Ray, S.; Ganguly, S.; Rajendiran, C.; Mitra, M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5® and Bifidobacterium BB-12® for prevention of antibiotic-associated diarrhoea. JAPI 2013, 61, 708-712.

De Vrese, M.; Kristen, H.; Rautenberg, P.; Laue, C.; Schrezenmeir, J. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pyloriactivity. J. Dairy Res. 2011, 78, 396-403.

Sheu, B.S.; Wu, J.J.; Lo, C.Y.; Wu, H.W.; Chen, J.H.; Lin, Y.S.; Lin, M. D. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 2002,16, 1669-1675.

Wang, K.Y.; Li, S.N.; Liu, C.S.; Perng, D.S.; Su, Y.C.; Wu, D.C.; Jan, C.M.; Lai, C.H.; Wang, T.N.; Wang, W. M. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr. 2004, 80, 737-741.

Sheu, B.S.; Cheng, H.C.; Kao, A.W.; Wang, S.T.; Yang, Y.J.; Yang, H.B.; Wu, J. J. Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am. J. Clin. Nutr. 2006, 83, 864-869.

Szajewska H., Guandalini S., Morelli L. et al. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials // J. Pediatr. Gastroenterol. Nutr. 2010. Vol. 51. № 2. P. 203-209.

Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation. World J Gastroenterol. 2010;16:69-75

Pitkala, K.H.; Strandberg, T.E.; Finne Soveri, U.H.; Ouwehand, A.C.; Poussa, T.; Salminen, S. Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. J. Nutr. Health Aging 2007, 11, 305-311.

Uchida, K.; Akashi, K.; Kusunoki, I.; Ikeda, T.; Katano, N.; Motoshima, H.; Benno, Y. Effect of fermented milk containing Bifidobacterium lactis BB-12® on stool frequency, defecation, fecal microbiota and safety of excessive ingestion in healthy female students. J. Nutr. Food 2005, 8, 39-51.

Nishida, S.; Gotou, M.; Akutsu, S.; Ono, M.; Hitomi, Y.; Nakamura, T.; Iino, H. Effect of yogurt containing Bifidobacterium lactis BB-12 on improvement of defecation and fecal microflora of healthy female adults. Milk Sci. 2004,53, 71-80.

Matsumoto, M.; Imai, T.; Hironaka, T.; Kume, H.; Watanabe, M.; Benno, Y. Effect of yoghurt with Bifidobacterium lactis LKM512 in improving fecal microflora and defecation of healthy volunteers. Intest. Microbiol. Mag. 2001, 14, 97-102.

Jungersen M., Wind A, Johansen E., Christensen J. E., Stuer-Lauridsen B., Eskesen D. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactisBB-12® Microorganisms 2014, 2(2), 92-110

Park H. Functional gastrointestinal disorders and overlap syndrome in Korea // J Gastroenterol Hepatol. 2011. Vol. 26 (suppl 3). Р. 12-14.

Ivanov D., Emonet C., Foata F. et al. A serpin from the gut bacterium Bifidobacteriumlongum inhibits eukaryotic elastase-like serine proteases // J. Biol. Chem. 2006. Vol. 281. Р. 17246-17252.

Buhner S., Li Q., Vignali S. et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome // Gastroenterology. 2009. Vol. 137. Р. 1425-1434.

Macfarlane S., Woodmansey E., Macfarlane G. Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system // Appl. Environ. Microbiol. 2005. Vol. 71. Р. 7483-7492.

Осадчук М. А., Осадчук М. М. Синдром перекреста функциональной диспепсии, гастроэзофагеальной рефлюксной болезни и синдрома раздраженного кишечника: оптимизация терапии // РМЖ. 2015. № 28. С. 1690-1692.

Wall G. C., Bryant G. A., Bottenberg M. M., Maki E. D., Miesner A. R. Irritable bowel syndrome: A concise review of current treatment concepts // World J Gastroenterol. 2014 July 21. Vol. 20 (27). Р. 8796-8806.

Захарова И. Н., Дмитриева Ю. А. Штамм-специфические свойства Bifidobacterium animalis subsp. lactis Bb-12. Педиатрия. № 2. 2013

Shamir R, et al. Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age. J Am Coll Nutr. 2005;24:370-5.

Simakachorn N, et al. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr. 2000;30:68-72

Bernet MF, et al. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 1994;35:483-9.

Juntunen M, et al. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol. 2001;8:293-6.

Huang JS, et al. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci. 2002;47:2625-34.

Van Niel CW, et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002;109:678-84.

Costa-Ribeiro H, et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr. 2003;36:112-5.

Kowalska-Duplaga K, et al. Efficacy of Trilacin the treatment of acute diarrhoea in infants and young children - a multicentre, randomized, double-blind placebo-controlled study. Pediatria Współczesna. 2004;3:295-9.

Szajewska H, et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001;138:361-5.

Allen SJ, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;(11): CD003048.

Sazawal S, et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006;6:374-82.

Lin HC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115:1-4.

Savilahti E, kuitunen M, Vaarala O. Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008; 8: 243-8.

The authors declare that there are no conflicts of interest present.